What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA approved the small-molecule inhibitor pimicotinib (Pimjetmi) for selected patients with symptomatic tenosynovial giant cell tumor (TGCT) and high surgical risk. An oral selective inhibitor of colony stimulating factor...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
People newly diagnosed with myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD, generally had a low risk of relapse and lasting disability, according to a Kaiser Permanente…
Children whose mothers have type 1 diabetes develop the disease at about half the rate of children whose fathers have it.
The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications…
The FDA is adding a new warning label onto GLP-1 drugs like Ozempic and Zepbound for a rare side effect with serious risk.
'Saw Rajiv smiling', P 13
Scientists are developing a new MRI-based test that could spare thousands of cancer patients from aggressive radiotherapy treatment.
